Drugs / Technetium
Technetium
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT07552597 Comparator | May 2026 → Dec 2029 expected | cutaneous melanoma | Vastra Gotaland Region | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT01495377 Background | Jan → May 2012 | — | Region Örebro County | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Technetium | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07552597 ↗ |
| Known as | 99mTc | “Technetium (99mTc)” NCT07552597 ↗ |
| Known as | Tc99 | “Technetium (Tc99) plus Blue Dye (BD)” NCT07552597 ↗ |
| Modality | Diagnostic / imaging agent | “Radioactive tracer” NCT07552597 ↗ |